Similar protein doses of 89Zr-OA-NBC and 111In-OA-NBC one-armed isotype controls for 89Zr-onartuzumab did not accumulate in tumour tissues, confirming the c-MET specificity of the 89Zr-onartuzumab signal. This evidence concerns the gene MET and neoplasm.